SLC2A3 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	43 studies	46% ± 20%	Explore
natural killer cell	34 studies	32% ± 13%	Explore
pericyte	33 studies	42% ± 20%	Explore
macrophage	32 studies	33% ± 13%	Explore
fibroblast	31 studies	31% ± 14%	Explore
CD4-positive, alpha-beta T cell	31 studies	44% ± 16%	Explore
CD8-positive, alpha-beta T cell	31 studies	36% ± 11%	Explore
B cell	29 studies	37% ± 13%	Explore
mast cell	29 studies	45% ± 17%	Explore
classical monocyte	29 studies	51% ± 17%	Explore
T cell	27 studies	40% ± 18%	Explore
monocyte	24 studies	41% ± 17%	Explore
conventional dendritic cell	24 studies	39% ± 13%	Explore
regulatory T cell	24 studies	44% ± 14%	Explore
smooth muscle cell	19 studies	30% ± 12%	Explore
mature NK T cell	18 studies	35% ± 12%	Explore
gamma-delta T cell	17 studies	34% ± 14%	Explore
memory B cell	17 studies	40% ± 15%	Explore
naive B cell	17 studies	37% ± 15%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	16 studies	36% ± 15%	Explore
dendritic cell	15 studies	37% ± 14%	Explore
non-classical monocyte	15 studies	26% ± 11%	Explore
capillary endothelial cell	15 studies	37% ± 10%	Explore
endothelial cell of vascular tree	15 studies	48% ± 18%	Explore
mucosal invariant T cell	14 studies	40% ± 15%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	34% ± 12%	Explore
myeloid cell	14 studies	38% ± 17%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	13 studies	34% ± 15%	Explore
vein endothelial cell	13 studies	42% ± 14%	Explore
endothelial cell of lymphatic vessel	12 studies	25% ± 11%	Explore
neutrophil	12 studies	55% ± 19%	Explore
endothelial cell of artery	12 studies	34% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	12 studies	32% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	11 studies	43% ± 15%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	50% ± 18%	Explore
connective tissue cell	11 studies	29% ± 11%	Explore
type I pneumocyte	10 studies	31% ± 12%	Explore
effector memory CD8-positive, alpha-beta T cell	10 studies	33% ± 11%	Explore
leukocyte	10 studies	29% ± 7%	Explore
microglial cell	9 studies	32% ± 18%	Explore
platelet	7 studies	29% ± 8%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	36% ± 12%	Explore
T follicular helper cell	7 studies	51% ± 22%	Explore
innate lymphoid cell	7 studies	32% ± 6%	Explore
alveolar macrophage	6 studies	32% ± 6%	Explore
CD4-positive helper T cell	6 studies	42% ± 11%	Explore
effector CD4-positive, alpha-beta T cell	6 studies	49% ± 3%	Explore
myofibroblast cell	6 studies	29% ± 10%	Explore
megakaryocyte	6 studies	61% ± 24%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	46% ± 17%	Explore
mononuclear phagocyte	5 studies	37% ± 11%	Explore
abnormal cell	5 studies	23% ± 9%	Explore
T-helper 17 cell	5 studies	47% ± 21%	Explore
adventitial cell	5 studies	25% ± 8%	Explore
intermediate monocyte	5 studies	50% ± 18%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	25% ± 7%	Explore
central memory CD8-positive, alpha-beta T cell	4 studies	27% ± 11%	Explore
plasmablast	4 studies	21% ± 6%	Explore
exhausted T cell	4 studies	33% ± 12%	Explore
lymphocyte	4 studies	32% ± 14%	Explore
group 3 innate lymphoid cell	4 studies	62% ± 19%	Explore
granulocyte	4 studies	54% ± 16%	Explore
type II pneumocyte	3 studies	22% ± 4%	Explore
plasmacytoid dendritic cell	3 studies	26% ± 5%	Explore
endothelial cell of sinusoid	3 studies	31% ± 16%	Explore
erythrocyte	3 studies	29% ± 9%	Explore
glomerular endothelial cell	3 studies	41% ± 8%	Explore
retinal ganglion cell	3 studies	51% ± 16%	Explore
extravillous trophoblast	3 studies	51% ± 18%	Explore
immature B cell	3 studies	47% ± 8%	Explore
tissue-resident macrophage	3 studies	35% ± 8%	Explore
Mueller cell	3 studies	34% ± 12%	Explore
epithelial cell	3 studies	38% ± 26%	Explore
monocyte-derived dendritic cell	3 studies	24% ± 4%	Explore
muscle cell	3 studies	31% ± 8%	Explore
GABAergic neuron	3 studies	31% ± 9%	Explore
glutamatergic neuron	3 studies	43% ± 13%	Explore
T-helper 1 cell	3 studies	53% ± 7%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	45% ± 18%	Explore
double negative thymocyte	3 studies	34% ± 16%	Explore
double-positive, alpha-beta thymocyte	3 studies	46% ± 28%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	32% ± 16%	Explore
mural cell	3 studies	35% ± 10%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	18 studies	32% ± 13%	Explore
lung	12 studies	30% ± 13%	Explore
intestine	5 studies	23% ± 5%	Explore
kidney	5 studies	29% ± 8%	Explore
eye	5 studies	21% ± 6%	Explore
brain	5 studies	29% ± 10%	Explore
placenta	4 studies	24% ± 6%	Explore
uterus	4 studies	31% ± 8%	Explore
lymph node	4 studies	41% ± 18%	Explore
breast	4 studies	24% ± 6%	Explore
bone marrow	3 studies	37% ± 4%	Explore
skin	3 studies	32% ± 9%	Explore
liver	3 studies	34% ± 9%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	19954.60	576 / 578	92%	41.07	1067 / 1155
breast	86%	15918.73	396 / 459	85%	18.70	945 / 1118
thymus	82%	9351.57	533 / 653	85%	30.70	517 / 605
brain	76%	4247.85	2014 / 2642	84%	24.93	594 / 705
skin	67%	4484.44	1203 / 1809	92%	58.48	436 / 472
kidney	60%	7186.31	53 / 89	76%	49.67	683 / 901
ovary	63%	4662.56	114 / 180	67%	15.32	288 / 430
prostate	55%	3844.03	134 / 245	74%	15.67	370 / 502
bladder	57%	6040.52	12 / 21	71%	25.46	358 / 504
uterus	56%	4038.11	96 / 170	69%	21.13	319 / 459
intestine	52%	4047.88	499 / 966	72%	19.76	379 / 527
esophagus	41%	3110.50	595 / 1445	78%	22.17	142 / 183
stomach	36%	2649.90	128 / 359	78%	21.15	223 / 286
adrenal gland	28%	2277.25	72 / 258	77%	32.90	178 / 230
spleen	100%	9898.31	241 / 241	0%	0	0 / 0
peripheral blood	100%	111105.40	926 / 929	0%	0	0 / 0
adipose	97%	22806.53	1172 / 1204	0%	0	0 / 0
pancreas	3%	111.93	11 / 328	91%	38.80	162 / 178
lymph node	0%	0	0 / 0	86%	31.00	25 / 29
blood vessel	80%	8216.63	1063 / 1335	0%	0	0 / 0
tonsil	0%	0	0 / 0	73%	13.95	33 / 45
heart	56%	6029.73	482 / 861	0%	0	0 / 0
liver	24%	1376.39	54 / 226	26%	5.42	106 / 406
muscle	45%	2026.53	358 / 803	0%	0	0 / 0
eye	0%	0	0 / 0	30%	4.12	24 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_1904659	Biological process	glucose transmembrane transport
GO_0098708	Biological process	glucose import across plasma membrane
GO_0150104	Biological process	transport across blood-brain barrier
GO_0015757	Biological process	galactose transmembrane transport
GO_0005975	Biological process	carbohydrate metabolic process
GO_0019852	Biological process	L-ascorbic acid metabolic process
GO_0015755	Biological process	fructose transmembrane transport
GO_0070837	Biological process	dehydroascorbic acid transport
GO_0046323	Biological process	glucose import
GO_0030667	Cellular component	secretory granule membrane
GO_0035579	Cellular component	specific granule membrane
GO_0005886	Cellular component	plasma membrane
GO_0016020	Cellular component	membrane
GO_0043204	Cellular component	perikaryon
GO_0070062	Cellular component	extracellular exosome
GO_0070821	Cellular component	tertiary granule membrane
GO_0101003	Cellular component	ficolin-1-rich granule membrane
GO_0042995	Cellular component	cell projection
GO_0016235	Cellular component	aggresome
GO_0005354	Molecular function	galactose transmembrane transporter activity
GO_0055056	Molecular function	D-glucose transmembrane transporter activity
GO_0033300	Molecular function	dehydroascorbic acid transmembrane transporter activity
GO_0005353	Molecular function	fructose transmembrane transporter activity
GO_0005536	Molecular function	D-glucose binding
GO_0005355	Molecular function	glucose transmembrane transporter activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	SLC2A3
Protein name	Solute carrier family 2 member 3 Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)
Synonyms	GLUT3
Description	FUNCTION: Facilitative glucose transporter . Can also mediate the uptake of various other monosaccharides across the cell membrane . Mediates the uptake of glucose, 2-deoxyglucose, galactose, mannose, xylose and fucose, and probably also dehydroascorbate . Does not mediate fructose transport . Required for mesendoderm differentiation (By similarity). .
Accessions	F5GYR5 P11169 ENST00000075120.12 F5GYX0 ENST00000544291.1 ENST00000707174.1 ENST00000544936.1

SLC2A3 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review